- Country: Germany
- Summary: Open House Original Discount Agreements 2021-05 Emtricitabine / Tenofovir Alafenamide / Rilpivirine (combination of Active Ingredients)
- DET Ref No: 49687976
- Deadline: 28 Feb 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 044481-2021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Document Type: Contract notice
Title: Open House Original Discount Agreements 2021-05 Emtricitabine / Tenofovir alafenamide / Rilpivirine (combination of active ingredients)
Reference Number: OH-Originals-2021-05
Contract Type: Supplies
Description: The health insurance companies involved are pursuing the goal of concluding discount agreements in accordance with Section 130c SGB V for the active ingredient combination emtricitabine / tenofovir alafenamide / rilpivirine with all suitable pharmaceutical companies. The contract is concluded within the framework of the open house originals procedure of the health insurance companies:
Individual negotiations about the content of the contract are not conducted, uniform terms apply. The health insurance companies do not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on 1.3.2021. The contract ends on February 28, 2023 at the latest, regardless of the date on which the contract was concluded. All further information can be found in the participation and contract documents. If the patent expires before February 28, 2023, the contract ends automatically at the end of the month in which the patent expires.
33600000 - Pharmaceutical products
Authority Type: Body governed by public law
Type ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOpen House Original Discount Agreements 2021-05 Emtricitabine / Tenofovir Alafenamide / Rilpivirine (combination of Active Ingredients) - Germany Tender
The TECHNIKER KRANKENKASSE, a Government sector organization in Germany, has announced a new tender for Open House Original Discount Agreements 2021-05 Emtricitabine / Tenofovir Alafenamide / Rilpivirine (combination of Active Ingredients). This tender is published on GermanyTenders under DET Ref No: 49687976 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-02-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
